NCT02683343

Brief Summary

Carpal tunnel syndrome (CTS) is a common condition that still lacks a reliable, objective screening test. Many anatomical aspects of the syndrome have been studied including the dimensions of the carpal tunnel and shape of the nerve within the tunnel. The investigators have observed varying amounts of muscle overlying the carpal tunnel in patients undergoing surgery for the condition. Assuming that this muscle may have a dynamic role in the development of the condition, the investigators attempted to quantify this muscle using ultrasound (US). The purpose of this study was to devise a technique to evaluate the amount of muscle overlying the carpal tunnel. The hypothesis is that patients with carpal tunnel syndrome will have significantly more muscle overlying the carpal tunnel than individuals without carpal tunnel syndrome.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jul 2016

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 16, 2015

Completed
6 months until next milestone

First Posted

Study publicly available on registry

February 17, 2016

Completed
5 months until next milestone

Study Start

First participant enrolled

July 1, 2016

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2018

Completed
Last Updated

January 25, 2018

Status Verified

July 1, 2015

Enrollment Period

2 years

First QC Date

August 16, 2015

Last Update Submit

January 24, 2018

Conditions

Outcome Measures

Primary Outcomes (1)

  • amount-depth of muscle overlying the carpal tunnel

    As determined by ultrasound

    2 years

Study Arms (2)

carpal tunnel syndrome

No intervention

normals

no intervention

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with the diagnosis of CTS and those without

You may qualify if:

  • The diagnosis of CTS will include signs and symptoms of CTS: nighttime numbness and tingling or numbness and tingling in a median nerve distribution with a positive phalen or tinel or forearm compression test as well as a nerve conduction test and electromyography (NCT and EMG) that is positive for CTS.
  • The normal subjects: individuals that do not have any signs and or symptoms of CTS.

You may not qualify if:

  • Patients or individuals that have a known history of peripheral neuropathy or other condition in the hand including recent significant trauma.
  • Patients with incomplete or unclear evaluation and tests.
  • Individuals unwilling to sign a consent form to participate in the study.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carpal Tunnel Syndrome

Condition Hierarchy (Ancestors)

Median NeuropathyMononeuropathiesPeripheral Nervous System DiseasesNeuromuscular DiseasesNervous System DiseasesNerve Compression SyndromesCumulative Trauma DisordersSprains and StrainsWounds and Injuries
0

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 16, 2015

First Posted

February 17, 2016

Study Start

July 1, 2016

Primary Completion

July 1, 2018

Study Completion

July 1, 2018

Last Updated

January 25, 2018

Record last verified: 2015-07